Mrs. Radha Sarvesh Sinai Narvencar follows a structured and documented approach for mutual fund scheme selection and investor profiling in accordance with applicable SEBI and AMFI guidelines. This policy outlines the framework adopted to align product distribution with investor profiles while maintaining transparency and regulatory compliance.
Investors are required to complete a Risk Profiling Assessment prior to undertaking investments. The risk profile is determined based on multiple factors including investment horizon, financial goals, income stability, investment experience, and risk tolerance. Risk profiles may be reviewed periodically or upon any material change in the investor's financial or personal circumstances.
Scheme selection is based on a structured evaluation process, which may include: alignment with investor risk profile and investment horizon; scheme category and asset class; historical performance across different market cycles; fund management experience and track record; portfolio characteristics and risk parameters; other relevant qualitative and quantitative factors.
Financial products are mapped to the investor's assessed risk profile and investment horizon. Investors are expected to review product-related information and make informed decisions before proceeding with any transaction.
Mrs. Radha Sarvesh Sinai Narvencar is an AMFI Registered Mutual Fund Distributor and provides distribution services only. We do not provide investment advisory services or portfolio management services. Investment decisions are undertaken at the discretion of the investor.
Mrs. Radha Sarvesh Sinai Narvencar does not have any ownership or affiliation with any Asset Management Company. Scheme selection is based on defined parameters and is not influenced by commissions or incentives. Commission earned from product providers is disclosed on the Commission Disclosures page.
Relevant records relating to investor profiling, transactions, and communications are maintained in accordance with applicable regulatory requirements.
This policy is reviewed periodically or upon any changes in applicable regulatory guidelines.